In this study, we replaced CD5 and CD23 with CD43 and CD180 and obtained a significantly improved sensitivity of 79.4% for the diagnosis of CD5 negative or CD23 negative CLL. The gene discussed is CD5; the disease is B-cell chronic lymphocytic leukemia.